Related Experiment Video
Updated: Dec 8, 2025
A Modified Simple Method for Induction of Myocardial Infarction in Mice
Published on: December 3, 2021
Ameliorative effect of ferruginol on isoprenaline hydrochloride-induced myocardial infarction in rats
Xudong Zhang1, Xiaojiang Li2, Chunlan Wang3
1Encephalopathy Center, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
Insights
Ferruginol (FGL) demonstrates significant cardioprotective effects against myocardial infarction (MI) in rats. This natural compound reduces cardiac damage markers and inflammation, offering potential for future MI treatments.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Natural Products Chemistry
Background:
- Cardiovascular diseases, particularly myocardial infarction (MI), remain a leading global cause of mortality.
- Current medical interventions for MI often have limitations and setbacks.
- Ferruginol (FGL), a polyphenol and terpenoid, exhibits known antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To investigate the cardioprotective potential of Ferruginol (FGL) in an experimental model of myocardial infarction (MI).
- To evaluate the effects of FGL on cardiac biomarkers, oxidative stress, and inflammation in isoprenaline hydrochloride (ISO)-induced MI in rats.
Main Methods:
- Myocardial infarction was induced in experimental rats using isoprenaline hydrochloride (ISO).
- Rats were treated with Ferruginol (FGL) at a dose of 50 mg/kg.
- Cardiac function, serum cardiac markers, oxidative stress indicators, antioxidant levels, ATPase activity, and pro-inflammatory cytokines were assessed.
- Histological analysis was performed to evaluate cardiac tissue damage.
Main Results:
- ISO-induced MI resulted in increased cardiac weight, elevated cardiac markers, enhanced lipid peroxidation, reduced endogenous antioxidants, decreased ATPase activity, and increased pro-inflammatory cytokines.
- FGL treatment significantly reduced heart weight, cardiac markers, and lipid peroxidation.
- FGL supplementation improved antioxidant status and decreased pro-inflammatory mediator levels (interleukin-6, tumor necrosis factor-α, nuclear factor-κB).
- Histological findings confirmed the cardioprotective role of FGL, reducing cardiac damage.
Conclusions:
- Ferruginol (FGL) exhibits significant cardioprotective effects in an ISO-induced rat model of MI.
- FGL mitigates cardiac damage by reducing oxidative stress and inflammation.
- These findings suggest FGL holds promise as a potential therapeutic agent for managing myocardial infarction.
Abstract:
Cardiovascular-related diseases continue to be a leading cause of death globally. Among ischemic-induced cardiac diseases, myocardial infarction (MI) is reported to be of an alarming value. Despite numerous improvements in the medical intrusions, still this armamentarium fails to be effective in managing the illness without setbacks. Ferruginol (FGL) is a major polyphenols and terpenoids with numerous pharmacological activities including antioxidant and anti-inflammatory. Following, this work was aimed to explore the cardio protective effect of FGL (50 mg/kg) in isoprenaline hydrochloride (ISO)-induced MI in experimental rats. After treatment with FGL in ISO-induced MI in rats, noticeable changes were observed in the experimental rats. Injection of ISO to rats resulted in the augmented cardiac weight, serum cardiac markers (creatine kinase, creatine kinase-MB, cardiac troponin T, and Cardiac troponin I), lipid peroxidation end products (thiobarbituric acid-reactive substance and lipid hydroperoxides), reduced endogenous antioxidants (superoxide dismutase, catalase, glutathione peroxidase, and glutathione), reduced ATPase activity, and escalated pro-inflammatory cytokines (interleukin-6, tumor necrosis factor-α, and nuclear factor-κB) levels. Interestingly, the FGL supplementation to the ISO-treated rats revealed the diminished heart weight, reduced cardiac markers, and lipid peroxidation. FGL also possessed the improved antioxidants status and diminished pro-inflammatory mediator levels. The outcomes of histological analysis also evidenced the cardio protective role of FGL. Treatment with FGL reduced the cardiac damage biomarkers maintained to near normal levels in ISO-induced rats. These study findings disclose the prospective capability of FGL in the treatment of MI in the future.
